In 1998, I was diagnosed with metastatic melanoma and given months to live. I consulted more than a dozen leading oncologists and got conflicting recommendations. No one could tell me: ‘Which treatment is best for me?’

A clinical trial saved my life—despite itself being unsuccessful—only raising more questions. Why did this therapy work for me but not for others? Could my experience help similar patients? It was life-saving knowledge I wanted to share with all cancer patients.

Welcome to Cancer Commons.

Marty Tenenbaum, PhD Founder of Cancer Commons

Since our founding in 2011, we have delivered personalized, evidence-based guidance at no charge to more than 10,000 patients and caregivers, supported entirely by philanthropy.

  • I am grateful for the concise and accurate summary of my treatment options. I have been waiting 3 years for this. Your goal to close the gap between metastatic trials and patients holds great promise to speed up success.

    Michelle Kendall
    Cancer patient

  • In my dark days I did not know how to explore trials for my husband. Cancer commons put me on the right path for all my options to explore. It is a load off my mind to know that I have some knowledge moving forward. Thank you for all your input!

    Cindy
    Wife of glioblastoma patient

  • Whenever we needed them they were there. Whenever we needed new information or help finding a new treatment they were there immediately. They were such a pleasure to deal with that they were like a family member helping you out, and believe me I/we needed them. 

    Dr. Mel Burchman
    Spouse of a pancreatic cancer patient
  • Tim is so helpful and we were so impressed with the detailed treatment options report that he sent. This cancer journey is overwhelming and it is comforting to have these services. A heartfelt thanks to Cancer Commons.

    Jill
    Glioblastoma patient

  • The best part of cancer commons is timely access to a tumor board. It gives reassurance to the patient and family that the current treatment approach is correct and that other options are available.

    Caregiver of a cancer patient

Cancer Commons is staffed by accomplished researchers with PhDs in the molecular biology and pharmacology of cancer and in Artificial Intelligence. They have joined the Commons to apply their knowledge and expertise to help patients research their options in real time using the latest tools of precision oncology.